| AHR | Airway hyper-responsiveness |
| ALP | Alkaline phosphatase |
| ALT | Alanine transaminase |
| AMD | Age-related macular degeneration |
| Apaf-1 | Protease activating factor-1 |
| ARE | Antioxidant response element |
| AST | Aspartate aminotransferase |
| ATP | Adenosine triphosphate |
| BAFFR | B-cell activating factor receptor |
| Bax | Bcl2-associated X protein |
| Bcl2 | B-cell lymphoma 2 |
| BMM | Bone Marrow-Derived Macrophages |
| CCI | Chronic constriction injury (CCI) |
| CCl4 | Carbon Tetrachloride |
| CD40 | Cluster of differentiation 40 |
| Cdc2 | Cell-Division Cycle 2 |
| Cdc25C | Cell division cycle 25 |
| CDK | Cyclin-dependent protein kinase |
| cFLIP | Cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein |
| CL | Clearance |
| CME | Coronary micro-embolization |
| CNC | Cap ‘n’ collar |
| CO | Carbon monoxide |
| DSS | Dextran sodium sulfate |
| E2F1 | E2F Transcription Factor 1 |
| EGF | Epidermal growth factor |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial-mesenchymal transition |
| ERK | Extracellular signal-regulated kinase |
| ERK1/2 | Extracellular signal-regulated kinases 1 and 2 |
| FADD | Fas-associated death domain |
| GRO1 | Growth Regulated Oncogene 1 |
| GST | Glutathione S-transferase |
| GTP | guanosine 5’-triphosphate |
| H2O2 | Hydrogen peroxide |
| HO-1 | Heme oxygenase-1 |
| IkBα | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
| IKK | IκB kinase |
| IL-13 | Interleukin-13 |
| IL-4 | Interleukin-4 |
| IL-5 | Interleukin-5 |
| IL-6 | Interleukin-6 |
| IR | Ischemia and reperfusion |
| LC3 | 1A/1B-light chain 3 |
| LTβR | Lymphotoxin beta receptor |
| MAPK | Mitogen-activated protein kinase |
| MCAO | Middle cerebral artery occlusion |
| MDA | Malondialdehyde |
| MEK | Mitogen-activated protein kinase kinase |
| MEK1/2 | Mitogen-activated protein kinase kinases 1 and 2 |
| MMP | Matrix metalloproteinases |
| mTOR | Mammalian target of rapamycin |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NF-kB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NIK | NF-κB-inducing kinase |
| NQO1 | NAD(P)H: quinone oxidoreductase 1 |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NSCLC | Non-small cell lung cancer. |
| OGD-RP | Oxygen-glucose deprivation-reperfusion |
| PAH | Pulmonary arterial hypertension |
| PARP | Poly ADP ribose polymerase |
| PI | Propidium Iodide |
| PI3K | Phosphatidylinositol-3 kinase and PI3 kinase. |
| Rb | Retinoblastoma Tumor Suppressor Protein |
| PRR | Pattern recognition receptor |
| RANK | Receptor activator of nuclear factor κB |
| RANKL | Receptor activator of nuclear factor κB ligand |
| ROS | Reactive oxygen species |
| RPE | Retinal pigment epithelium |
| RTK | Receptor tyrosine kinase |
| SFDA | Chinese state food and drug administration |
| Snail | Zinc finger protein SNAI1 |
| Th17 | T helper cell 17 |
| T1/2 | Half-life |
| Tmax | Time to reach maximum concentration |
| TNFR | TNF receptors TNFR1 |
| TNF-α | Tumor Necrosis Factor alpha |
| TRAIL | Tumor Necrosis Factor-Alpha-Related Apoptosis-Inducing Ligand |
| TRAIL-R1/2 | Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor 1/2 |
| Tregs | Regulatory T-cells |
| Twist1 | Twist-related protein 1 |
| Vd | Apparent volume of distribution |
| XAR | Xenobiotic-activated receptor (XAR) |